Bangkok Genomics Innovation PCL (BKK:BKGI) FCF Margin %: -77.89% (As of Dec. 2025)


BKK:BKGI Bangkok Genomics Innovation PCL BKK:BKGI
45 GF Score
Price ฿2.02
! 12 Warning Signs
View Full Analysis

What is Bangkok Genomics Innovation PCL FCF Margin %?

Bangkok Genomics Innovation PCL BKK:BKGI -2.88% 45 FCF Margin % is -77.89% as of Dec. 2025. GuruFocus rates BKK:BKGI with a GF Score™ of 45/100. The stock has 12 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, Bangkok Genomics Innovation PCL ranks worse than 72.91% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bangkok Genomics Innovation PCL's Free Cash Flow for the three months ended in Dec. 2025 was ฿-110.8 Mil. Bangkok Genomics Innovation PCL's Revenue for the three months ended in Dec. 2025 was ฿142.3 Mil. Therefore, Bangkok Genomics Innovation PCL's FCF Margin % for the quarter that ended in Dec. 2025 was -77.89%.

As of today, Bangkok Genomics Innovation PCL's current FCF Yield % is -10.61%.

The historical rank and industry rank for Bangkok Genomics Innovation PCL's FCF Margin % or its related term are showing as below:

BKK:BKGI' s FCF Margin % Range Over the Past 10 Years
Min: -33.88   Med: 9.48   Max: 27.21
Current: -33.88

During the past 7 years, the highest FCF Margin % of Bangkok Genomics Innovation PCL was 27.21%. The lowest was -33.88%. And the median was 9.48%.

BKK:BKGI's FCF Margin % is ranked worse than
72.91% of 203 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.89 vs BKK:BKGI: -33.88

Bangkok Genomics Innovation PCL FCF Margin % Related Terms

Bangkok Genomics Innovation PCL FCF Margin % Historical Data

* Premium members only.

The historical data trend for Bangkok Genomics Innovation PCL's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bangkok Genomics Innovation PCL FCF Margin % Chart

Bangkok Genomics Innovation PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 11.09 17.25 27.21 -6.95 -33.88

Bangkok Genomics Innovation PCL Quarterly Data
Dec19 Dec20 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.00 -11.57 12.15 -19.30 -77.89

BKK:BKGI vs TMO, DHR, IDXX: FCF Margin % Comparison

For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bangkok Genomics Innovation PCL FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bangkok Genomics Innovation PCL's FCF Margin % falls into.


BKK:BKGI
45GF Score
Bangkok Genomics Innovation PCL BKK:BKGI
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bangkok Genomics Innovation PCL FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bangkok Genomics Innovation PCL's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-128.581/379.511
=-33.88 %

Bangkok Genomics Innovation PCL's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-110.816/142.264
=-77.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -77.89% mean?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a FCF Margin % of -77.89% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bangkok Genomics Innovation PCL and its competitors. According to the industry distribution chart, Bangkok Genomics Innovation PCL ranks #148 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 72.9%.
Is Bangkok Genomics Innovation PCL's FCF Margin % too high?
Bangkok Genomics Innovation PCL's current FCF Margin % is -77.89%. Based on the distribution chart, Bangkok Genomics Innovation PCL ranks #148 out of 203 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Bangkok Genomics Innovation PCL has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Genomics Innovation PCL's FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Bangkok Genomics Innovation PCL ranks #148 out of 203 companies for FCF Margin %. This places Bangkok Genomics Innovation PCL in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bangkok Genomics Innovation PCL and its competitors. Bangkok Genomics Innovation PCL's current FCF Margin % is -77.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Genomics Innovation PCL stock overvalued right now?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a current FCF Margin % of -77.89%. The current FCF Margin % is -77.89%. Bangkok Genomics Innovation PCL's overall GF Score™ is 45/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Bangkok Genomics Innovation PCL (BKK:BKGI), the current FCF Margin % is -77.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bangkok Genomics Innovation PCL Business Description

Address 3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Sale of laboratory reagents and related products; Testing and analysis services, which derives maximum revenue; and Sale and advanced therapy medicinal product.
45GF Score

Get the complete analysis for BKK:BKGI

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿2.02
Price